pubmed-article:1546723 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0001688 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0521362 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0014806 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0017970 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0879626 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
pubmed-article:1546723 | lifeskim:mentions | umls-concept:C1550147 | lld:lifeskim |
pubmed-article:1546723 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:1546723 | pubmed:dateCreated | 1992-4-10 | lld:pubmed |
pubmed-article:1546723 | pubmed:abstractText | To determine the frequency of gastrointestinal toxicity due to intravenous (IV) erythromycin and to attempt to decrease this toxicity by prolonging the infusion time of erythromycin and/or pretreating with the peripheral anticholinergic, glycopyrrolate 0.1 mg IV. | lld:pubmed |
pubmed-article:1546723 | pubmed:language | eng | lld:pubmed |
pubmed-article:1546723 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1546723 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:1546723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1546723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1546723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1546723 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1546723 | pubmed:month | Mar | lld:pubmed |
pubmed-article:1546723 | pubmed:issn | 0002-9343 | lld:pubmed |
pubmed-article:1546723 | pubmed:author | pubmed-author:OldfieldE... | lld:pubmed |
pubmed-article:1546723 | pubmed:author | pubmed-author:BowlerW AWA | lld:pubmed |
pubmed-article:1546723 | pubmed:author | pubmed-author:SamuelsonDD | lld:pubmed |
pubmed-article:1546723 | pubmed:author | pubmed-author:HostettlerCC | lld:pubmed |
pubmed-article:1546723 | pubmed:author | pubmed-author:LavinB SBS | lld:pubmed |
pubmed-article:1546723 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1546723 | pubmed:volume | 92 | lld:pubmed |
pubmed-article:1546723 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1546723 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1546723 | pubmed:pagination | 249-53 | lld:pubmed |
pubmed-article:1546723 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:meshHeading | pubmed-meshheading:1546723-... | lld:pubmed |
pubmed-article:1546723 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1546723 | pubmed:articleTitle | Gastrointestinal side effects of intravenous erythromycin: incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment. | lld:pubmed |
pubmed-article:1546723 | pubmed:affiliation | Department of Internal Medicine, Naval Hospital, San Diego, California 92134-5000. | lld:pubmed |
pubmed-article:1546723 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1546723 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:1546723 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:1546723 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |